Phase II trial of rhIL-6 (interleukin-6) prior to and concurrently with VAD (vincristine, doxorubicin and dexamethasone) chemotherapy for patients with multiple myeloma

Citation

• Young, R. I., Ranson, M., Chang, J., Lord, B., Testa, N., & Scarffe, J. H. (1997). Phase II trial of rhIL-6 (interleukin-6) prior to and concurrently with VAD (vincristine, doxorubicin and dexamethasone) chemotherapy for patients with multiple myeloma. EUROPEAN JOURNAL OF CANCER, 33(2), 307-311. doi:10.1016/S0959-8049(96)00383-8

Digital Object Identifier (doi)

• 10.1016/S0959-8049(96)00383-8

Web Of Science Accession Number

• WOS:A1997WR85200032

Number Of Pages

• 5

Start Page

• 307

End Page

• 311

Volume

• 33

Issue

• 2

Abstract

UOW Authors

•   Ranson, Marie (external author)

Publication Date

• 1997

Publisher

• PERGAMON-ELSEVIER SCIENCE LTD 

Published In

• EUROPEAN JOURNAL OF CANCER  Journal

Citation

• Young, R. I., Ranson, M., Chang, J., Lord, B., Testa, N., & Scarffe, J. H. (1997). Phase II trial of rhIL-6 (interleukin-6) prior to and concurrently with VAD (vincristine, doxorubicin and dexamethasone) chemotherapy for patients with multiple myeloma. EUROPEAN JOURNAL OF CANCER, 33(2), 307-311. doi:10.1016/S0959-8049(96)00383-8

Digital Object Identifier (doi)

• 10.1016/S0959-8049(96)00383-8

Web Of Science Accession Number

• WOS:A1997WR85200032

Number Of Pages

• 5

Start Page

• 307

End Page

• 311

Volume

• 33

Issue

• 2